YOU ARE HERE > MONEYCONTROL > MARKETS > PHARMACEUTICALS > News - Natco Pharma

Natco Pharma

BSE: 524816|NSE: NATCOPHARM|ISIN: INE987B01026|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Jun 18, 16:00
1095.15
14 (1.29%)
VOLUME 57,274
LIVE
NSE
Jun 18, 15:56
1095.80
13.5 (1.25%)
VOLUME 1,291,810
News on Natco Pharma
Select Year: 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2000-2005
Natco Pharma Standalone March 2021 Net Sales at Rs 311.50 crore, down 25.85% Y-o-Y

8.33 pm | 17 Jun 2021 |  Source: Moneycontrol.com

NULL...

Natco Pharma Consolidated March 2021 Net Sales at Rs 331.30 crore, down 27.15% Y-o-Y

8.33 pm | 17 Jun 2021 |  Source: Moneycontrol.com

NULL...

Natco Pharma's marketing partner gets USFDA nod for anti-cancer drug

12.18 pm | 14 Jun 2021 |  Source: PTI

"Breckenridge Pharmaceutical Inc. (BPI), has received approval for its abbreviated new drug application (ANDA) for Carfilzomib Vials ANDA (generic for...

Natco Pharma share price hits 52- week high on DCGI nod for production of 'Black Fungus' drug

9.58 am | 24 May 2021 |  Source: Moneycontrol.com

DCGI approved application of five companies incuding Natco Pharma to begin production of antifungal drug Amphotericin B liposomal injection, which is ...

Five pharma cos get permission to produce antifungal drug Amphotericin B liposomal injection

9.35 pm | 20 May 2021 |  Source: Moneycontrol.com

The five companies that got permission to manufacture are Natco Pharma, Gufic Biosciences, Alembic Pharmaceuticals, Emcure Pharmaceuticals and Lyca Ph...

COVID-19 drug Baricitinib: Eli Lilly signs voluntary licensing agreement with Natco Pharma

9.28 am | 17 May 2021 |  Source: Moneycontrol.com

Natco has received approval from the Drug Controller General of India (DCGI) for Baricitinib earlier in May. Natco went ahead and launched the drug un...

Hot Stocks | Natco Pharma, Dredging Corporation, Hatsun Agro can give up to 28% return in short term

7.17 am | 11 May 2021 |  Source: Moneycontrol.com

A strong advance-decline ratio in the consolidating market indicates the chances of an upward trend sooner or later....

COVID-19 treatment: Eli Lilly partners with Cipla, Lupin, Sun Pharma to manufacture, distribute Baricitinib in India

9.09 am | 10 May 2021 |  Source: Moneycontrol.com

Eli Lilly said it iwa also in discussions with several other Indian manufacturers for the potential grant of additional voluntary licenses....

Natco Pharma Consolidated December 2020 Net Sales at Rs 355.20 crore, down 26.34% Y-o-Y

6.00 pm | 11 Feb 2021 |  Source: Moneycontrol.com

NULL...

Natco Pharma Standalone December 2020 Net Sales at Rs 330.90 crore, down 26.09% Y-o-Y

6.00 pm | 11 Feb 2021 |  Source: Moneycontrol.com

NULL...

1 2
Quick Links for Natco Pharma
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.